503 related articles for article (PubMed ID: 18274766)
1. Increment in beta-hCG in the 48-h period prior to treatment: a new variable predictive of therapeutic success in the treatment of ectopic pregnancy with methotrexate.
da Costa Soares R; Elito J; Camano L
Arch Gynecol Obstet; 2008 Oct; 278(4):319-24. PubMed ID: 18274766
[TBL] [Abstract][Full Text] [Related]
2. Are early human chorionic gonadotropin levels after methotrexate therapy a predictor of response in ectopic pregnancy?
Nguyen Q; Kapitz M; Downes K; Silva C
Am J Obstet Gynecol; 2010 Jun; 202(6):630.e1-5. PubMed ID: 20510964
[TBL] [Abstract][Full Text] [Related]
3. Single-dose methotrexate for the treatment of unruptured ectopic pregnancy.
Erdem M; Erdem A; Arslan M; Oç A; Biberoğlu K; Gürsoy R
Arch Gynecol Obstet; 2004 Dec; 270(4):201-4. PubMed ID: 12955534
[TBL] [Abstract][Full Text] [Related]
4. Do serum beta-human chorionic gonadotropin levels on day 4 following methotrexate treatment of patients with ectopic pregnancy predict successful single-dose therapy?
Gabbur N; Sherer DM; Hellmann M; Abdelmalek E; Phillip P; Abulafia O
Am J Perinatol; 2006 Apr; 23(3):193-6. PubMed ID: 16586235
[TBL] [Abstract][Full Text] [Related]
5. Safety and efficacy of systemic methotrexate in the treatment of unruptured tubal pregnancy.
Soliman KB; Saleh NM; Omran AA
Saudi Med J; 2006 Jul; 27(7):1005-10. PubMed ID: 16830020
[TBL] [Abstract][Full Text] [Related]
6. Pre- and post-treatment patterns of human chorionic gonadotropin for early detection of persistence after a single dose of methotrexate for ectopic pregnancy.
Natale A; Candiani M; Barbieri M; Calia C; Odorizzi MP; Busacca M
Eur J Obstet Gynecol Reprod Biol; 2004 Nov; 117(1):87-92. PubMed ID: 15474251
[TBL] [Abstract][Full Text] [Related]
7. Role of initial and day 4 human chorionic gonadotropin levels in predicting the outcome of single-dose methotrexate treatment in women with tubal ectopic pregnancy.
Ustunyurt E; Duran M; Coskun E; Ustunyurt ÖB; Simşek H
Arch Gynecol Obstet; 2013 Nov; 288(5):1149-52. PubMed ID: 23666603
[TBL] [Abstract][Full Text] [Related]
8. Trichosanthin, a Chinese medicine for the medical treatment of ectopic pregnancy with high levels of β-hCG.
Xiang DJ; Chen LM; Gu JS; Stone P; Chen Q
Reprod Sci; 2012 May; 19(5):534-8. PubMed ID: 22267541
[TBL] [Abstract][Full Text] [Related]
9. Medical treatment of ectopic pregnancy: a ten-year review of 106 cases at Maharaj Nakorn Chiang Mai Hospital.
Srivichai K; Uttavichai C; Tongsong T
J Med Assoc Thai; 2006 Oct; 89(10):1567-71. PubMed ID: 17128828
[TBL] [Abstract][Full Text] [Related]
10. Single-dose methotrexate for ectopic pregnancy treatment: preliminary data.
Merisio C; Anfuso S; Berretta R; Gualdi M; Pultrone DC; Melpignano M
Acta Biomed; 2005 Apr; 76(1):33-6. PubMed ID: 16116823
[TBL] [Abstract][Full Text] [Related]
11. Methotrexate-treated ectopic pregnancy: beta human chorionic gonadotropin serum changes as a success predictor using a mathematical model validation.
Kovaleva A; Irishina N; Pereira A; Cuesta-Guardiola T; Ortiz-Quintana L
Eur J Obstet Gynecol Reprod Biol; 2017 Mar; 210():35-38. PubMed ID: 27936449
[TBL] [Abstract][Full Text] [Related]
12. Predicting success of methotrexate treatment by pretreatment HCG level and 24-hour HCG increment.
Levin G; Saleh NA; Haj-Yahya R; Matan LS; Avi B
Int J Gynaecol Obstet; 2018 Apr; 141(1):70-73. PubMed ID: 29154410
[TBL] [Abstract][Full Text] [Related]
13. Second-dose methotrexate in ectopic pregnancies: the role of beta human chorionic gonadotropin.
Cohen A; Bibi G; Almog B; Tsafrir Z; Levin I
Fertil Steril; 2014 Dec; 102(6):1646-9. PubMed ID: 25241368
[TBL] [Abstract][Full Text] [Related]
14. The role of HCG increment in the 48h prior to methotrexate treatment as a predictor for treatment success.
Cohen A; Almog B; Cohen Y; Bibi G; Rimon E; Levin I
Eur J Obstet Gynecol Reprod Biol; 2017 Apr; 211():103-107. PubMed ID: 28214759
[TBL] [Abstract][Full Text] [Related]
15. A validation of the most commonly used protocol to predict the success of single-dose methotrexate in the treatment of ectopic pregnancy.
Kirk E; Condous G; Van Calster B; Haider Z; Van Huffel S; Timmerman D; Bourne T
Hum Reprod; 2007 Mar; 22(3):858-63. PubMed ID: 17088266
[TBL] [Abstract][Full Text] [Related]
16. The conservative management of interstitial pregnancy.
Jermy K; Thomas J; Doo A; Bourne T
BJOG; 2004 Nov; 111(11):1283-8. PubMed ID: 15521876
[TBL] [Abstract][Full Text] [Related]
17. ß-hCG and prediction of therapeutic success in ectopic pregnancies treated with methotrexate, results from a prospective observational study.
Orozco EM; Sánchez-Durán MA; Bello-Muñoz JC; Sagalá J; Carreras E; Roura LC
J Matern Fetal Neonatal Med; 2015 Apr; 28(6):695-9. PubMed ID: 24871360
[TBL] [Abstract][Full Text] [Related]
18. [Limits of ambulatory medical treatment of ectopic pregnancies by intramuscular methotrexate: prospective study on 54 patients].
Perdu M; Camus E; Rozenberg P; Dano D; Pavard A; Goffinet F; Philippe HJ; Nisand I
Contracept Fertil Sex; 1998 Jan; 26(1):59-65. PubMed ID: 9532884
[TBL] [Abstract][Full Text] [Related]
19. An alternative monitoring protocol for single-dose methotrexate therapy in ectopic pregnancy.
Thurman AR; Cornelius M; Korte JE; Fylstra DL
Am J Obstet Gynecol; 2010 Feb; 202(2):139.e1-6. PubMed ID: 19962125
[TBL] [Abstract][Full Text] [Related]
20. Cut-off value of initial serum β-hCG level predicting a successful MTX therapy in tubal ectopic pregnancy: a retrospective cohort study.
Helmy S; Bader Y; Pablik E; Tiringer D; Pils S; Laml T; Kölbl H; Koch M
Eur J Obstet Gynecol Reprod Biol; 2014 Aug; 179():175-80. PubMed ID: 24956362
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
